- Home
- IMXI vs TNGX Comparison
IMXI vs TNGX Comparison
Compare IMXI & TNGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMXI
- TNGX
- Stock Information
- Founded
- IMXI 1994
- TNGX 2014
- Country
- IMXI United States
- TNGX United States
- Employees
- IMXI N/A
- TNGX N/A
- Industry
- IMXI Retail: Computer Software & Peripheral Equipment
- TNGX Biotechnology: Pharmaceutical Preparations
- Sector
- IMXI Technology
- TNGX Health Care
- Exchange
- IMXI Nasdaq
- TNGX Nasdaq
- Market Cap
- IMXI 302.5M
- TNGX 351.2M
- IPO Year
- IMXI N/A
- TNGX N/A
- Fundamental
- Price
- IMXI $10.30
- TNGX $6.01
- Analyst Decision
- IMXI Buy
- TNGX Strong Buy
- Analyst Count
- IMXI 7
- TNGX 6
- Target Price
- IMXI $19.60
- TNGX $12.20
- AVG Volume (30 Days)
- IMXI 318.6K
- TNGX 2.7M
- Earning Date
- IMXI 08-06-2025
- TNGX 08-06-2025
- Dividend Yield
- IMXI N/A
- TNGX N/A
- EPS Growth
- IMXI 1.60
- TNGX N/A
- EPS
- IMXI 1.70
- TNGX N/A
- Revenue
- IMXI $652,547,000.00
- TNGX $40,990,000.00
- Revenue This Year
- IMXI N/A
- TNGX N/A
- Revenue Next Year
- IMXI $3.03
- TNGX N/A
- P/E Ratio
- IMXI $6.02
- TNGX N/A
- Revenue Growth
- IMXI N/A
- TNGX 10.09
- 52 Week Low
- IMXI $9.76
- TNGX $1.03
- 52 Week High
- IMXI $22.38
- TNGX $12.02
- Technical
- Relative Strength Index (RSI)
- IMXI 45.01
- TNGX 76.36
- Support Level
- IMXI $10.22
- TNGX $5.34
- Resistance Level
- IMXI $10.87
- TNGX $6.40
- Average True Range (ATR)
- IMXI 0.34
- TNGX 0.50
- MACD
- IMXI 0.05
- TNGX -0.02
- Stochastic Oscillator
- IMXI 48.65
- TNGX 84.08
About IMXI International Money Express Inc.
International Money Express Inc is a processor of money transfer services in the USA to the Latin America and the Caribbean (LAC) corridor. The company offers wire transfer, money order, Foreign exchange, and cash checking services, while the majority of the revenue is derived from wire transfer and money order fees. The firm's business is organized around one reportable segment that provides money remittance services between the U.S. and Canada to Mexico, Guatemala, and other countries in Latin America, Africa, and Asia.
About TNGX Tango Therapeutics Inc.
Tango Therapeutics Inc is a biotechnology company. It is dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. It is currently developing two MTA-cooperative PRMT5 inhibitors; TNG462 for non-CNS cancers, including pancreatic and lung cancer, and TNG456, a next-generation, brain-penetrant PRMT5 inhibitor, for CNS cancers, including GBM. Its pipeline products are PRMT5 and CoREST.